Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Depressive Disorder, Treatment-resistant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT06230757
What this trial is testing

Psilocybin for Treatment-Resistant Depression

Who this might be right for
Major Depressive DisorderAnhedoniaTreatment Resistant Depression
University of Colorado, Denver 20
Not applicableUnknownNCT04998773
What this trial is testing

Efficacy and Biomarkers of Response of TBS in Treatment Resistant Depression

Who this might be right for
Resistant Depression, TreatmentBipolar Depression
Instituto de Investigacion Sanitaria La Fe 96
Not applicableLooking for participantsNCT06462196
What this trial is testing

Natural History of Depression, Bipolar Disorder and Suicide Risk

Who this might be right for
Behavioral SymptomsSuicideSelf-Injurious Behavior+18 more
National Institute of Mental Health (NIMH) 500
Testing effectiveness (Phase 2)Study completedNCT00809562
What this trial is testing

RO4917523 in Patients With Treatment Resistant Depression

Who this might be right for
Depression
Hoffmann-La Roche 46
Large-scale testing (Phase 3)Study completedNCT00287703
What this trial is testing

Pulsed Electro Magnetic Fields (PEMF) Treatment in Patients With Treatment-Resistant Major Depression in Ongoing Pharmacological Treatment of Depression

Who this might be right for
Depression
Hillerod Hospital, Denmark 50
Large-scale testing (Phase 3)WithdrawnNCT00273624
What this trial is testing

Olanzapine Augmentation Therapy in Treatment-resistant Depression: a Double-blind Placebo-controlled Trial

Who this might be right for
Therapy-resistant Depression
University Hospital Freiburg
Not applicableApproved For MarketingNCT03829579
What this trial is testing

Pre-Approval Access to Esketamine Nasal Spray for the Treatment of Treatment-Resistant Depression (TRD)

Who this might be right for
Depressive Disorder, Treatment-Resistant
Janssen Research & Development, LLC
Not applicableActive Not RecruitingNCT07112261
What this trial is testing

Avatar Therapy in Virtual Reality for Treatment-Resistant Major Depressive Disorder: A Pilot Study

Who this might be right for
Treatment-Resistant Major Depressive Disorder
Ciusss de L'Est de l'Île de Montréal 15
Not applicableNot Yet RecruitingNCT07824973
What this trial is testing

Ketamine Treatment for Treatment-Resistant Depression - the Role of Framing

Who this might be right for
Treatment Resistant Depression (TRD)
Valdemar Landgren 120
Post-approval studies (Phase 4)Study completedNCT00253266
What this trial is testing

Venlafaxine Augmentation in Treatment Resistant Depression

Who this might be right for
Depression
Max-Planck-Institute of Psychiatry 126
Not applicableTemporarily pausedNCT04202770
What this trial is testing

Focused Ultrasound and Exosomes to Treat Depression, Anxiety, and Dementias

Who this might be right for
Refractory DepressionAnxiety DisordersNeurodegenerative Diseases
Neurological Associates of West Los Angeles 300
Post-approval studies (Phase 4)Study completedNCT05531591
What this trial is testing

RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)

Who this might be right for
DepressionDementiaMild Cognitive Impairment+5 more
Centre for Addiction and Mental Health 87
Not applicableActive Not RecruitingNCT07184697
What this trial is testing

Efficacy and Safety of Task-specific, Biomarker-driven, HD-ctACS inTRD.

Who this might be right for
Major Depression
Ruijin Hospital 10
Testing effectiveness (Phase 2)Study completedNCT00671515
What this trial is testing

Pioglitazone for the Treatment of Major Depressive Disorder Comorbid With Metabolic Syndrome

Who this might be right for
Depressive Disorder, MajorMetabolic Syndrome X
Joseph Calabrese, MD 23
Large-scale testing (Phase 3)Active Not RecruitingNCT05711940
What this trial is testing

Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD

Who this might be right for
Treatment Resistant Depression
COMPASS Pathways 572
Not applicableWithdrawnNCT04195308
What this trial is testing

SAINT for Treatment of Preoperative Depression to Reduce Opioid Use Following Arthroplasty

Who this might be right for
Treatment Resistant Depression
Stanford University
Testing effectiveness (Phase 2)Study completedNCT00633399
What this trial is testing

Ziprasidone Augmentation of SSRIs for Patients With Major Depressive Disorder (MDD) That do Not Sufficiently Respond to Treatment With SSRIs

Who this might be right for
Major Depressive Disorder
Massachusetts General Hospital 458
Testing effectiveness (Phase 2)Study completedNCT00034229
What this trial is testing

Clinical Trial of Felbamate for Treatment-Resistant Bipolar Depression

Who this might be right for
Bipolar Disorder
National Institute of Mental Health (NIMH) 52
Not applicableUnknownNCT00441636
What this trial is testing

Treatment Resistant Depression and Obstructive Sleep Apnea, Effect of Continuous Positive Airway Pressure (CPAP)

Who this might be right for
DepressionSleep Apnea, Obstructive
Queen's University 120
Not applicableStudy completedNCT01331330
What this trial is testing

European Deep Brain Stimulation (DBS) Depression Study

Who this might be right for
Depressive Disorder, Major
Abbott Medical Devices 9
Next Page